Periscope Capital’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Periscope Capital’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-867,072	Closed	-$48.6K	–	626
2023 Q3	$48.6K	Hold	867,072	–	–	0.01%	374
2023 Q2	$122K	Hold	867,072	–	–	0.01%	339
2023 Q1	$75.4K	Hold	867,072	–	–	﹤0.01%	483
2022 Q4	$37.1K	Buy	867,072 +131,500	+18%	+$6.72K	﹤0.01%	607
2022 Q3	$97K	Buy	735,572 +610,672	+489%	+$68.1K	﹤0.01%	627
2022 Q2	$17K	Hold	124,900	–	–	﹤0.01%	995
2022 Q1	$29K	Buy	+124,900	New	+$32.4K	﹤0.01%	1062

Periscope Capital's BIOSW Position: Q4 2023 in Review

Periscope Capital sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 867,072 shares — an estimated $48.6K sold.

Periscope Capital first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $122K in Q2 2023. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Periscope Capital reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Periscope Capital sold 867,072 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $48.6K.
Periscope Capital first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Periscope Capital's BioPlus Acquisition Corp. Warrants position peaked at $122K in Q2 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Periscope Capital's 13F filing for Q4 2023, filed 13 Feb 2024.